In an effort to enhance our technical capabilities and ensure that we deliver an optimal webinar experience during this challenging period, we will be postponing the date of this webinar to:
Date: 12 May 2020, Tuesday
Time: 9am to 10am Singapore Time
All previous registrants to this event will soon receive an invite to register their interest for the webinar on the new event date of 12 May. Kindly keep an eye out for this invite.
The MedTech industry faces a rapidly changing healthcare ecosystem across the entire Asia Pacific region. This flux has ignited interest in different methods of assessing medical technologies to inform value-based decision-making, one of which is Health Technology Assessment.
In partnership with IQVIA MedTech, APACMed has recently launched a new white paper: The Evolving Health Technology Assessment for Medical Devices and Diagnostics in the Asia Pacific Region and Key Considerations for Value Assessment Frameworks.
This authoritative report addresses the different levels of understanding around which, when and how medical technologies should be evaluated and is ideal for agencies looking to grow their knowledge base in policy and reimbursement decision making.
Join us for an exclusive webinar on Thursday, 26th March 2020, where we will hear from IQVIA Asia Pacific's Sirinthip Petcharapiruch and Boston Scientific's Virginia Priest as they share key takeaways from the paper and crucially discuss objectives and opportunities to collaboratively support value-driven medical technology assessments going forward.
Please register your interest to participate in this upcoming webinar. To download the White Paper, please click on this link: http://bit.ly/HTAWhitePaper
Login details for the webinar will be shared with registrants closer to the event date.